二氧化碳动力学方法测量危重症患者呼气末肺容积的临床验证
这项前瞻性研究纳入46例计划行诊断性CT检查的机械通气危重症患者(其中25例为ARDS,24例为COVID-19),比较基于呼出二氧化碳动力学连续测量的EELV(EELVCO2,分未校正和校正组织溶解CO2量两种)与CT参考EELV(EELVCT)。EELVCT和EELVCO2较理论功能残气量均显著降低(分别降低39%和40%,p<0.0001)。未校正EELVCO2倾向于高估EELVCT(r²=0.58,偏差-285 ml,95%CI LoA +513至-1083 ml);校正后一致性改善(偏差-23 ml,LoA +763至-716 ml);校正EELVCO2与功能性EELVCT一致性最佳(r²=0.59,偏差-2.75 ml,LoA +755至-761 ml)。ARDS与非ARDS患者间方法性能未见重大差异。作者认为,若在进一步验证中确认,EELVCO2可能成为危重症机械通气患者连续监测EELV的有吸引力的监测选择。
要点
- 在46例机械通气危重症患者中,校正EELVCO2与功能性EELVCT一致性最佳:r²=0.59,偏差-2.75 ml,95%CI LoA +755至-761 ml。
- 未校正EELVCO2倾向于高估EELVCT:r²=0.58,偏差-285 ml,95%CI LoA +513至-1083 ml;校正组织溶解CO2后偏差改善至-23 ml(LoA +763至-716 ml)。
- EELVCT和EELVCO2较理论功能残气量均显著降低(分别降低39%和40%,p<0.0001)。
- ARDS(多数为COVID相关)与非ARDS患者间,该方法性能未见重大差异。
- 作者认为,若在进一步验证中确认,EELVCO2可能成为危重症机械通气患者连续监测EELV的监测选择。
适用人群与场景
- 计划行诊断性CT检查的机械通气危重症患者,最终分析46例,其中25例诊断为ARDS(24例为COVID-19)。
研究设计与关键结果
- 前瞻性研究,纳入计划行诊断性CT检查的机械通气危重症患者46例,其中25例ARDS(24例COVID-19)。
- EELVCT和EELVCO2较理论功能残气量均显著降低(分别降低39%和40%,p<0.0001)。
- 未校正EELVCO2倾向于高估EELVCT:r²=0.58,偏差-285 ml,95%CI LoA +513至-1083 ml。
- 校正EELVCO2与EELVCT比较:偏差-23 ml,95%CI LoA +763至-716 ml,一致性较未校正改善。
- 校正EELVCO2与功能性EELVCT比较一致性最佳:r²=0.59,偏差-2.75 ml,95%CI LoA +755至-761 ml。
- ARDS(多数为COVID相关)与非ARDS患者间,该方法性能未见重大差异。
证据类型、等级与局限
- 证据类型:前瞻性临床验证研究。
- 局限:作者指出这是该方法在危重症患者中的首次验证,结论需在进一步验证中确认。
对床旁实践的改变
- 作者认为,若在进一步验证中确认,EELVCO2可能成为危重症机械通气患者连续监测EELV的监测选择。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
RATIONALE: End-expiratory lung volume (EELV) is reduced in mechanically ventilated patients, especially in pathologic conditions. The resulting heterogeneous distribution of ventilation increases the risk for ventilation induced lung injury. Clinical measurement of EELV however, remains difficult.
OBJECTIVE: Validation of a novel continuous capnodynamic method based on expired carbon dioxide (CO2) kinetics for measuring EELV in mechanically ventilated critically-ill patients.
METHODS: Prospective study of mechanically ventilated patients scheduled for a diagnostic computed tomography exploration. Comparisons were made between absolute and corrected EELVCO2 values, the latter accounting for the amount of CO2 dissolved in lung tissue, with the reference EELV measured by computed tomography (EELVCT). Uncorrected and corrected EELVCO2 was compared with total CT volume (density compartments between - 1000 and 0 Hounsfield units (HU) and functional CT volume, including density compartments of - 1000 to - 200HU eliminating regions of increased shunt. We used comparative statistics including correlations and measurement of accuracy and precision by the Bland Altman method.
MEASUREMENTS AND MAIN RESULTS: Of the 46 patients included in the final analysis, 25 had a diagnosis of ARDS (24 of which COVID-19). Both EELVCT and EELVCO2 were significantly reduced (39 and 40% respectively) when compared with theoretical values of functional residual capacity (p < 0.0001). Uncorrected EELVCO2 tended to overestimate EELVCT with a correlation r2 0.58; Bias - 285 and limits of agreement (LoA) (+ 513 to - 1083; 95% CI) ml. Agreement improved for the corrected EELVCO2 to a Bias of - 23 and LoA of (+ 763 to - 716; 95% CI) ml. The best agreement of the method was obtained by comparison of corrected EELVCO2 with functional EELVCT with a r2 of 0.59; Bias - 2.75 (+ 755 to - 761; 95% CI) ml. We did not observe major differences in the performance of the method between ARDS (most of them COVID related) and non-ARDS patients.
CONCLUSION: In this first validation in critically ill patients, the capnodynamic method provided good estimates of both total and functional EELV. Bias improved after correcting EELVCO2 for extra-alveolar CO2 content when compared with CT estimated volume. If confirmed in further validations EELVCO2 may become an attractive monitoring option for continuously monitor EELV in critically ill mechanically ventilated patients.
TRIAL REGISTRATION: clinicaltrials.gov (NCT04045262).
参考来源
- Sanchez Giralt JA, Tusman G, Wallin M, et al. Clinical validation of a capnodynamic method for measuring end-expiratory lung volume in critically ill patients. Crit Care. 2024. PMID: 38689313. doi:10.1186/s13054-024-04928-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。